In addition to recent developments in lung cancer care, attendees will hear from outgoing IASLC President Dr. Paul Van Schil and incoming President Dr. Caicun Zhou.

Investigators Wenfeng Fang, MD, PhD, and Fei Zhou, MD, PhD, share results from mono, combination studies of iza-bren. The data will be discussed during an oral abstract session Monday afternoon.

In a Q&A with ILCN, Gisele Fraga Moreira discusses the role of targeted therapies in lung cancer care and managing toxicities with new treatments.

Dr. Triparna Sen will explore how shifts in tumor biology—from small cell to non-small cell lung cancer and beyond—fuel plasticity, resistance, and metastasis.

The association’s Cancer Care Team Award recognizes the importance of specialists from multiple disciplines working together to provide optimal patient care.

Dr. Mary Pasquinelli said that Sybil shows promise for improving early detection and addressing disparities in lung cancer outcomes.

Drs. Pasi A. Jänne, Witold Rzyman, Sanja Dacic, and Solange Peters were celebrated for their outstanding contributions to thoracic oncology.

On Sunday morning, Dr. Paul Van Schil will chair the final Presidential Symposium of his term, focusing on innovative treatments and therapies.

Enrica Capelletto, MD, PhD, aims to raise awareness about alternatives to conventional smoking to prevent nicotine dependence.